Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

NCT06333951 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Thoracic Tumors
Non-small Cell Lung Cancer

Interventions

DRUG: Anvumetostat
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Pembrolizumab
DRUG: Pemetrexed
DRUG: Sotorasib

Sponsor

Amgen